A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients

Status:
Recruiting

Trial end date:
2022-10-01

Target enrollment:

Participant gender:

This is a pilot phase II study to evaluate the safety and efficacy of AND017 in NDD-CKD patients

Phase 2

Kind Pharmaceuticals LLC